Sumitomo Dainippon Pharma Annual Report 2017
57/102

Consumer Issues•Initiative for Access to Healthcare (see p. 5, 18, 56)•Initiatives for Stable Supply (see p. 29-30)•Initiatives to Provide High-quality Pharmaceuticals (see p. 31-32)•Recognizing and Understanding the Needs of Our Customers (see p. 30, 32, 56)•Communication with Customers (see p. 32)Running a Medical Information Website, a Health Information Website, and a Pharmaceuticals Information CenterMajor Items Reported on Our Websitehttp://www.accessaccelerated.org/Initiatives to Improve Access to HealthcareImproving access to healthcare is one of the important missions of a pharmaceutical company. Sumitomo Dainippon Pharma is actively striving to improve access to healthcare in order to help achieve Goal 3 of the United Nations’ Sustainable Development Goals: “Good Health and Well-being.” Additionally, since we recognize that global health is an issue on a worldwide scale, we value the importance of SDG 17, “Partnerships for the Goals,” and are working towards solutions by collaborating with government agencies, international institutions, research institutions, and civil society.As a partnership activity with 24 pharmaceutical companies doing business globally, Sumitomo Dainippon Pharma is striving to improve access to care for non-infectious diseases in low- and lower middle income countries, focusing on Africa and Asia.Access AcceleratedSumitomo Dainippon Pharma provides a health improvement program for mothers and children in the Kampong Cham District, Cambodia. Working with a nonprofit organization (NPO), local governments, and communities, we are striving to provide health checkups for infant and pregnant women, regular education and training on nutrition and hygiene, and home visits by healthcare providers.Health Improvement Program for Mothers and ChildrenWorking with NPOs, local governments, and local communities in Zambia, Tanzania, and Indonesia, Sumitomo Dainippon Pharma is distributing mosquito nets and simple test kits, in addition to carrying out education support activities and, inside Japan, hosting malaria education events.Initiatives to Control MalariaSumitomo Dainippon Pharma is supporting capacity building and patient advocacy as a part of efforts to improve access to healthcare. This includes implementing a project for training nurses in Bangladesh, a project for training physicians and implementing medical examinations for tuberculosis in Haiti.Capacity Building and Patient AdvocacySumitomo Dainippon Pharma participates in the Global Health Innovative Technology (GHIT) Fund. Through participation in the GHIT Fund, we are exploring the possibilities to apply our innovative drug discovery technologies to neglected tropical diseases (NTDs) and malaria, for which there are significant unmet medical needs.Participating in the GHIT Fundhttp://www.acchttp://wwwaccInitiatives to Improve Access to HealthcareImproving access to healthcare is one of the important missions of a pharmaceuticalcompany. Sumitomo Dainippon Pharma is actively striving to improve access to recognize that global health is an issue on a worldwide scale, we value the importance of SDG 17, “Partnerships for the Goals,” and are workingtowards solutions by *Page numbers refer to those in this pamphlet56Sumitomo Dainippon Pharma Co., Ltd. Annual Report 2017

元のページ  ../index.html#57

このブックを見る